The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Calhoun Christopher J since 2006.
The trader's CIK number is 1168215.
At the time of the last reporting, Calhoun Christopher J was the Chief Executive Offi of Plus Therapeutics, Inc.. (stock ticker symbol PSTV).
Also see all insider trading activities at Plus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CYTX | 0 | $0 | 29,145 | $1,244,287 | 0 | $0 |
| 2012 | CYTX | 0 | $0 | 205,000 | $831,069 | 205,000 | $633,449 |
| 2010 | CYTX | 0 | $0 | 48,125 | $274,697 | 0 | $0 |
| 2009 | CYTX | 16,850 | $48,676 | 0 | $0 | 62,500 | $187,500 |
| 2008 | CYTX | 0 | $0 | 53,190 | $439,508 | 53,190 | $7,978 |
| 2007 | CYTX | 0 | $0 | 50,000 | $263,000 | 0 | $0 |
| 2006 | CYTX | 20,000 | $97,474 | 57,060 | $442,839 | 57,060 | $8,556 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-01-10 | CYTX | Sale | 29,145 | 42.69 | 1,244,287 |
| 2012-02-02 | CYTX | Option Ex | 182,150 | 3.09 | 562,843 |
| 2012-02-03 | CYTX | Option Ex | 22,850 | 3.09 | 70,606 |
| 2012-02-02 | CYTX | Sale | 182,150 | 4.05 | 738,618 |
| 2012-02-03 | CYTX | Sale | 22,850 | 4.05 | 92,451 |
| 2010-12-22 | CYTX | Sale | 48,125 | 5.71 | 274,697 |
| 2009-12-21 | CYTX | Option Ex | 62,500 | 3.00 | 187,500 |
| 2009-05-20 | CYTX | Buy | 6,600 | 2.92 | 19,272 |
| 2009-05-19 | CYTX | Buy | 3,250 | 2.99 | 9,717 |
| 2009-05-15 | CYTX | Buy | 3,500 | 2.79 | 9,765 |
| 2009-05-18 | CYTX | Buy | 3,500 | 2.83 | 9,922 |
| 2008-06-10 | CYTX | Option Ex | 53,190 | .15 | 7,978 |
| 2008-06-10 | CYTX | Sale | 53,190 | 8.26 | 439,508 |
| 2007-08-22 | CYTX | Sale | 50,000 | 5.26 | 263,000 |
| 2006-12-14 | CYTX | Buy | 6,000 | 5.09 | 30,558 |
| 2006-12-13 | CYTX | Buy | 6,000 | 4.87 | 29,220 |
| 2006-12-11 | CYTX | Buy | 4,000 | 4.77 | 19,076 |
| 2006-12-08 | CYTX | Buy | 4,000 | 4.66 | 18,620 |
| 2006-07-05 | CYTX | Sale | 60 | 7.50 | 450 |
| 2006-07-05 | CYTX | Option Ex | 60 | .15 | 9 |
| 2006-05-11 | CYTX | Option Ex | 83 | .15 | 12 |
| 2006-05-10 | CYTX | Sale | 11,877 | 8.06 | 95,728 |
| 2006-05-11 | CYTX | Sale | 83 | 8.09 | 671 |
| 2006-05-10 | CYTX | Option Ex | 11,877 | .15 | 1,781 |
| 2006-05-08 | CYTX | Sale | 2,800 | 8.06 | 22,568 |
| 2006-05-04 | CYTX | Option Ex | 3,400 | .15 | 510 |
| 2006-05-05 | CYTX | Option Ex | 140 | .15 | 21 |
| 2006-05-04 | CYTX | Sale | 3,400 | 8.06 | 27,404 |
| 2006-05-05 | CYTX | Sale | 140 | 8.06 | 1,128 |
| 2006-05-08 | CYTX | Option Ex | 2,800 | .15 | 420 |
| 2006-05-02 | CYTX | Sale | 200 | 8.06 | 1,612 |
| 2006-05-02 | CYTX | Option Ex | 200 | .15 | 30 |
| 2006-05-01 | CYTX | Sale | 8,000 | 8.06 | 64,480 |
| 2006-05-01 | CYTX | Option Ex | 8,000 | .15 | 1,200 |
| 2006-03-14 | CYTX | Option Ex | 480 | .15 | 72 |
| 2006-03-14 | CYTX | Sale | 480 | 7.50 | 3,600 |
| 2006-03-02 | CYTX | Option Ex | 200 | .15 | 30 |
| 2006-03-02 | CYTX | Sale | 200 | 7.55 | 1,510 |
| 2006-02-27 | CYTX | Sale | 500 | 7.50 | 3,750 |
| 2006-02-27 | CYTX | Option Ex | 500 | .15 | 75 |
| 2006-02-24 | CYTX | Sale | 500 | 7.50 | 3,750 |
| 2006-02-23 | CYTX | Sale | 935 | 7.50 | 7,012 |
| 2006-02-24 | CYTX | Option Ex | 500 | .15 | 75 |
| 2006-02-23 | CYTX | Option Ex | 935 | .15 | 140 |
| 2006-02-17 | CYTX | Sale | 8,673 | 7.50 | 65,047 |
| 2006-02-17 | CYTX | Option Ex | 8,673 | .15 | 1,300 |
| 2006-02-21 | CYTX | Sale | 3,988 | 7.51 | 29,949 |
| 2006-02-21 | CYTX | Option Ex | 3,988 | .15 | 598 |
| 2006-02-14 | CYTX | Option Ex | 1,450 | .15 | 217 |
| 2006-02-14 | CYTX | Sale | 1,450 | 7.50 | 10,875 |
| 2006-02-16 | CYTX | Option Ex | 13,774 | .15 | 2,066 |
| 2006-02-16 | CYTX | Sale | 13,774 | 7.50 | 103,305 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Calhoun Christopher J (Chief Executive Offi of Plus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.